Skip to content
Screener

Teleflex TFX Americas — Research and development expenses

Other segment segments

EMEA
$26.33M+236%
Asia
$3.51M-29.3%

Similar metrics at other companies

Titan International logo
TWIConsumer — Research and development expenses
$1.01M+13.3%
Titan International logo
TWIAgriculture — Research and development expenses
$1.49M+9.7%
Baxter International logo
BAXPharmaceuticals — Research and development expenses
$22M-15.4%
CNH Industrial N.V. logo
CNHAgriculture — Research and development expenses
$205M+25.8%
CNH Industrial N.V. logo
CNHConstruction — Research and development expenses
$27M+28.6%
Kratos Defense & Security Solutions logo
KTOSUS — Research and development expenses
$800K+100%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%—

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity1×+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemAmericasEMEAAsiaSegment Total
Net revenues$348,838$145,531$75,963$570,332
Cost of goods sold116,52056,02530,926203,471
Research and development expenses12,97626,3333,50942,818
Selling, general and administrative expenses77,05654,78026,514158,350
Segment operating profit (1)$142,286$8,393$15,014$165,693

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's americas — research and development expenses?
Teleflex (TFX) reported americas — research and development expenses of $12.98M in Q2 2026.
How has Teleflex's americas — research and development expenses changed year-over-year?
Teleflex's americas — research and development expenses increased by 13.1% year-over-year, from $11.48M to $12.98M.
What is the long-term trend for Teleflex's americas — research and development expenses?
Over 2 years (2022 to 2025), Teleflex's americas — research and development expenses has grown at a -11.7% compound annual growth rate (CAGR), from $67.8M to $52.85M.
What does americas — research and development expenses mean?
Represents the investment in innovation, product development, and clinical trials specifically allocated to the Americas segment. These expenditures are critical for maintaining a competitive pipeline of medical technologies and regulatory compliance.

Ask your AI about Teleflex's americas — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude